S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDAapproved anti-helminthic agent niclosamide

Rachel L. Stewart, Brittany L. Carpenter, Dava S. West, Teresa Knifley, Lili Liu, Chi Wang, Heidi L. Weiss, Tamas S. Gal, Eric B. Durbin, Susanne M. Arnold, Kathleen L. O'Connor, Min Chen

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDAapproved anti-helminthic agent niclosamide'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology